Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irwin Chaiken

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
AIDS Research and Human Retroviruses|April 12, 2003
Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120Zhiwei Wu, Donald Van Ryk, Cheryl Davis, et al.
Proteins|March 10, 2007
A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactionsKaryn McFadden, Simon Cocklin, Hosahudya Gopi, et al.
Proteins|January 6, 2017
Recognition of HIV-inactivating peptide triazoles by the recombinant soluble Env trimer, BG505 SOSIP.664Kriti Acharya, Adel A Rashad, Francesca Moraca, et al.
Research Square|May 3, 2023
Pharmacophore Variants of the Macrocyclic Peptide Triazole Inactivator of HIV-1 EnvMonisha Gupta, Gabriela Canziani, Charles Ang, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 28, 2019
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomesRachna Aneja, Antonella Grigoletto, Aakansha Nangarlia, et al.
Journal of Molecular Recognition : JMR|March 1, 2002
Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5Chuanzhao Li, Carmela G Plugariu, Joanna Bajgier, et al.
Biochemistry|January 25, 2006
Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activationTetsuya Ishino, Udaya Pillalamarri, Dominick Panarello, et al.
Journal of Medicinal Chemistry|April 11, 2015
Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120Rachna Aneja, Adel A Rashad, Huiyuan Li, et al.
The Biochemical Journal|January 19, 2018
Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virusBibek Parajuli, Kriti Acharya, Harry C Bach, et al.
Biopolymers|March 30, 2004
Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alphaPiotr Ruchala, Gyorgyi Varadi, Tetsuya Ishino, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
AIDS Research and Human Retroviruses|April 12, 2003
Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120Zhiwei Wu, Donald Van Ryk, Cheryl Davis, et al.
Proteins|March 10, 2007
A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactionsKaryn McFadden, Simon Cocklin, Hosahudya Gopi, et al.
Proteins|January 6, 2017
Recognition of HIV-inactivating peptide triazoles by the recombinant soluble Env trimer, BG505 SOSIP.664Kriti Acharya, Adel A Rashad, Francesca Moraca, et al.
Research Square|May 3, 2023
Pharmacophore Variants of the Macrocyclic Peptide Triazole Inactivator of HIV-1 EnvMonisha Gupta, Gabriela Canziani, Charles Ang, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 28, 2019
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomesRachna Aneja, Antonella Grigoletto, Aakansha Nangarlia, et al.
Journal of Molecular Recognition : JMR|March 1, 2002
Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5Chuanzhao Li, Carmela G Plugariu, Joanna Bajgier, et al.
Biochemistry|January 25, 2006
Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activationTetsuya Ishino, Udaya Pillalamarri, Dominick Panarello, et al.
Journal of Medicinal Chemistry|April 11, 2015
Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120Rachna Aneja, Adel A Rashad, Huiyuan Li, et al.
The Biochemical Journal|January 19, 2018
Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virusBibek Parajuli, Kriti Acharya, Harry C Bach, et al.
Biopolymers|March 30, 2004
Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alphaPiotr Ruchala, Gyorgyi Varadi, Tetsuya Ishino, et al.
Pageof 6